The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Open accessAbstract
Nuclear exclusion of the PTEN (phosphatase and tensin homologue deleted in chromosome 10) tumour suppressor has been associated with cancer progression. However, the mechanisms leading to this aberrant PTEN localization in human cancers are currently unknown. We have previously reported that ubiquitinylation of PTEN at specific lysine residues regulates its nuclear-cytoplasmic partitioning. Here we show that functional promyelocytic leukaemia protein (PML) nuclear bodies co-ordinate PTEN localization by opposing the action of a previously unknown PTEN-deubiquitinylating enzyme, herpesvirus-associated ubiquitin-specific protease (HAUSP, also known as USP7), and that the integrity of this molecular framework is required for PTEN to be able to enter the nucleus. We find that PTEN is aberrantly localized in acute promyelocytic leukaemia, in which PML function is disrupted by the PML-RARalpha fusion oncoprotein. Remarkably, treatment with drugs that trigger PML-RARalpha degradation, such as all-trans retinoic acid or arsenic trioxide, restore nuclear PTEN. We demonstrate that PML opposes the activity of HAUSP towards PTEN through a mechanism involving the adaptor protein DAXX (death domain-associated protein). In support of this paradigm, we show that HAUSP is overexpressed in human prostate cancer and is associated with PTEN nuclear exclusion. Thus, our results delineate a previously unknown PML-DAXX-HAUSP molecular network controlling PTEN deubiquitinylation and trafficking, which is perturbed by oncogenic cues in human cancer, in turn defining a new deubiquitinylation-dependent model for PTEN subcellular compartmentalization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of HAUSP is localized in the nucleus”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Song et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Sundaram, S. K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T. R., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,719
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Tenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,050
Self-citationEssential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Self-citationStructure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 876
Self-citationRNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M., Shen, L., Plechanovová, A., Hattersley, N., Jaffray, E., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 837
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
Self-citation
Cited by
Sorted by citations
Items 101–200 of 546
USP7 - a crucial regulator of cancer hallmarks
Saha, G., Roy, S., Basu, M., & Ghosh, M. K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188903 · Cited by 109
PML is a ROS sensor activating p53 upon oxidative stress
Niwa-Kawakita, M., Ferhi, O., Soilihi, H., Le Bras, M., Lallemand-Breitenbach, V., & de Thé, H. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160301 · Cited by 104
Man, X., Piao, C., Lin, X., Kong, C., Cui, X., & Jiang, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1262-4 · Cited by 102
Yang, W.-L., Zhang, X., & Lin, H.-K. (2010) · Oncogene · doi:10.1038/onc.2010.190 · Cited by 103
DUBs, the regulation of cell identity and disease
Heideker, J., & Wertz, I. E. (2014) · Biochemical Journal · doi:10.1042/bj20140496 · Cited by 108
The function, regulation and therapeutic implications of the tumor suppressor protein, PML
Guan, D., & Kao, H. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0051-9 · Cited by 99
Goncalves, M. B. C. V., Malmqvist, T., Clarke, E. E., Hubens, C. J., Grist, J., Hobbs, C., Trigo, D., Risling, M., Angéria, M., Damberg, P., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1339-15.2015 · Cited by 99
The role of PML in the control of apoptotic cell fate: a new key player at ER–mitochondria sites
Pinton, P., Giorgi, C., & Pandolfi, P. P. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.31 · Cited by 97
Self-citationNoncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase
Zhao, Y. J., Majid, M. C., Soll, J. M., Brickner, J. R., Dango, S., & Mosammaparast, N. (2015) · The EMBO Journal · doi:10.15252/embj.201490497 · Cited by 97
Geurink, P. P., Oualid, F. E., Jonker, A. M., Hameed, D. S., & Ovaa, H. (2011) · ChemBioChem · doi:10.1002/cbic.201100706 · Cited by 97
Edelmann, M. J., Nicholson, B., & Kessler, B. M. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002031 · Cited by 97
Regulation of USP7: A High Incidence of E3 Complexes
Kim, R. Q., & Sixma, T. K. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.05.028 · Cited by 97
Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium
Mafficini, A., & Scarpa, A. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0560 · Cited by 98
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
Jin, Q., Martinez, C. A., Arcipowski, K. M., Zhu, Y., Gutierrez-Diaz, B. T., Wang, K. K., Johnson, M. R., Volk, A. G., Wang, F., Wu, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1740 · Cited by 98
Kirkin, V., & Đikić, I. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.004 · Cited by 95
Regulation of pluripotency and differentiation by deubiquitinating enzymes
Suresh, B., Lee, J., Kim, S., & Ramakrishna, S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.53 · Cited by 93
The functional roles of PML nuclear bodies in genome maintenance
Chang, H. R., Munkhjargal, A., Kim, M.-J., Park, S. Y., Jung, E. Y., Ryu, J., Yang, Y. D., Lim, J., & Kim, Y. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.05.002 · Cited by 103
USP7 controls Chk1 protein stability by direct deubiquitination.
Alonso-de Vega, I., Martín, Y., & Smits, V. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973324 · Cited by 92
p85 Associates with Unphosphorylated PTEN and the PTEN-Associated Complex
Rabinovsky, R., Pochanard, P., McNear, C. J., Brachmann, S. M., Duke‐Cohan, J. S., Garraway, L. A., & Sellers, W. R. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01649-08 · Cited by 92
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma
Franqui-Machin, R., Hao, M., Bai, H., Gu, Z., Zhan, X., Habelhah, H., Jethava, Y. S., Qiu, L., Frech, I., Tricot, G. J. K., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98765 · Cited by 93
Deubiquitination of Ci/Gli by Usp7/HAUSP Regulates Hedgehog Signaling
Zhou, Z., Yao, X., Li, S., Xiong, Y., Dong, X., Zhao, Y., Jiang, J., & Zhang, Q. H. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.05.016 · Cited by 90
Ouyang, L., Yan, B., Liu, Y., Mao, C., Wang, M., Liu, N., Wang, Z., Liu, S., Shi, Y., Chen, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0181-3 · Cited by 87
Xu, P., Xiao, H., Yang, Q., Hu, R., Lianyong, J., Bi, R., Jiang, X., Wang, L., Mei, J., Ding, F., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0356-6 · Cited by 87
Kouranti, I., McLean, J. R., Feoktistova, A., Liang, P., Johnson, A. E., Roberts-Galbraith, R. H., & Gould, K. L. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000471 · Cited by 89
Kreis, P., Leondaritis, G., Lieberam, I., & Eickholt, B. J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00023 · Cited by 87
Zhao, G., Lin, Z., Lu, C., Gu, J., Yuan, Y., Xu, F., Liu, R., Ge, D., & Ding, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2773-4 · Cited by 86
He, Y., Jiang, S., Mao, C., Zheng, H., Cao, B., Zhang, Z., Zhao, J., Zeng, Y., & Mao, X. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101088 · Cited by 84
Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.
Dar, A., Shibata, E., & Dutta, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-13 · Cited by 83
DAXX represents a new type of protein-folding enabler
Huang, L., Agrawal, T., Zhu, G., Yu, S., Tao, L., Lin, J., Marmorstein, R., Shorter, J., & Yang, X. (2021) · Nature · doi:10.1038/s41586-021-03824-5 · Cited by 83
Yi, L., Cui, Y., Xu, Q., & Jiang, Y. (2016) · Oncology Reports · doi:10.3892/or.2016.5099 · Cited by 83
PTEN arginine methylation by PRMT6 suppresses PI3K–AKT signaling and modulates pre-mRNA splicing
Feng, J., Dang, Y., Zhang, W., Zhao, X., Zhang, C., Hou, Z., Jin, Y., McNutt, M. A., Marks, A. R., & Yin, Y. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811028116 · Cited by 82
PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation
Shen, S.-M., Zhang, C., Ge, M.-K., Dong, S.-S., Li, X., He, P., Zhang, N., Ji, Y., Yang, S., Yu, Y., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0409-z · Cited by 82
USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma
Lu, C., Ning, Z., Wang, A., Chen, D., Liu, X., Xia, T., Tekcham, D. S., Wang, W., Li, T., Liu, X., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.032 · Cited by 81
Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors
Carracedo, A., Baselga, J. M., & Pandolfi, P. P. (2008) · Cell Cycle · doi:10.4161/cc.7.24.7244 · Cited by 84
Self-citationRoles of HAUSP-mediated p53 regulation in central nervous system development
Kon, N., Zhong, J., Kobayashi, Y., Li, M., Szabolcs, M., Ludwig, T., Canoll, P. D., & Gu, W. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.12 · Cited by 79
The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells
Sacco, J. J., Yau, T. Y., Darling, S., Patel, V., Liu, H., Urbé, S., Clague, M. J., & Coulson, J. M. (2013) · Oncogene · doi:10.1038/onc.2013.512 · Cited by 78
Carrà, G., Panuzzo, C., Torti, D., Parvis, G. E., Crivellaro, S., Familiari, U., Volante, M., Morena, D., Lingua, M. F., Brancaccio, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16348 · Cited by 78
Self-citationReiner, T., Parrondo, R. D., Pozas, A. D. L., Palenzuela, D. L., & Perez‐Stable, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056234 · Cited by 77
Park, S. H., Fong, K.-W., Kim, J., Wang, F., Lü, X., Lee, Y., Brea, L. T., Wadosky, K. M., Guo, C., Abdulkadir, S. A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe2261 · Cited by 78
The multiple layers of non-genetic regulation of PTEN tumour suppressor activity
Correia, N., Gírio, A., Antunes, I., Martins, L. R., & Barata, J. T. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.017 · Cited by 77
Agathanggelou, A., Smith, E., Davies, N. J., Kwok, M., Zlatanou, A., Oldreive, C. E., Mao, J., Da Costa, D., Yadollahi, S., Perry, T., et al. (2017) · Blood · doi:10.1182/blood-2016-12-758219 · Cited by 75
Regulation and modulation of PTEN activity
Naderali, E., Khaki, A. A., Rad, J. S., Alihemmati, A., Rahmati, M., & Charoudeh, H. N. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4321-6 · Cited by 78
PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression
Park, M. K., Yao, Y., Xia, W., Setijono, S. R., Kim, J. H., Vila, I. K., Chiu, H.-H., Wu, Y., González‐Billalabeitia, E., Lee, M. G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08481-x · Cited by 77
Self-citationMorotti, A., Panuzzo, C., Crivellaro, S., Pergolizzi, B., Familiari, U., Berger, A. H., Saglio, G. N., & Pandolfi, P. P. (2013) · Leukemia · doi:10.1038/leu.2013.370 · Cited by 76
Self-citationRegulation of the tumor suppressor PTEN by SUMO
González, J., Campagna, M., Ortega-Molina, A., Marcos-Villar, L., de la Cruz-Herrera, C. F., González, D., Gallego, P. P. F., Lopitz‐Otsoa, F., Estéban, M., Rodríguez, M. S., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.135 · Cited by 74
Morra, F., Merolla, F., Napolitano, V., Ilardi, G., Miro, C., Paladino, S., Staibano, S., Cerrato, A., & Celetti, A. (2017) · Oncotarget · doi:10.18632/oncotarget.16463 · Cited by 74
Functional analysis of deubiquitylating enzymes in tumorigenesis and development
Cheng, J., Guo, J., North, B. J., Wang, B., Cui, C., Li, H., Tao, K., Zhang, L., & Wei, W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188312 · Cited by 75
van der Knaap, J. A., Kozhevnikova, E. N., Langenberg, K. P. S., Moshkin, Y. M., & Verrijzer, C. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01121-09 · Cited by 72
Study of PTEN subcellular localization
Bononi, A., & Pinton, P. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.002 · Cited by 72
Pfoh, R., Lacdao, I. K., Georges, A. A., Capar, A., Zheng, H. X., Frappier, L., & Saridakis, V. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004950 · Cited by 76
Identification and structure-guided development of pyrimidinone based USP7 inhibitors
O’Dowd, C. R., Helm, M. D., Rountree, J. S. S., Flasz, J. T., Arkoudis, E., Miel, H., Hewitt, P. R., Jordan, L., Barker, O., Hughes, C., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00512 · Cited by 71
USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells
Lee, J. E., Park, C. M., & Kim, J. H. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2019-0338 · Cited by 72
Yi, J., Li, H., Chu, B., Kon, N., Hu, X., Hu, J., Xiong, Y., Kanıskan, H. Ü., Jin, J. J., & Gu, W. J. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01180-7 · Cited by 70
Chen, S.-T., Okada, M., Nakato, R., Izumi, K., Bando, M., & Shirahige, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628255 · Cited by 69
Protein monoubiquitylation: targets and diverse functions
Nakagawa, T., & Nakayama, K. (2015) · Genes to Cells · doi:10.1111/gtc.12250 · Cited by 76
Wei, R., Liu, X., Yu, W., Yang, T., Cai, W., Liu, J., Huang, X. S., Xu, G., Zhao, S., Yang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3671 · Cited by 72
Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer
da Silva, H. B., Amaral, E. P., Nolasco, E. L., de Victo, N. C., Atique, R., Jank, C. C., Anschau, V., Zerbini, L. F., & Correa, R. G. (2013) · Prostate Cancer · doi:10.1155/2013/920612 · Cited by 73
RFP-mediated ubiquitination of PTEN modulates its effect on AKT activation
Lee, J. T., Shan, J., Zhong, J., Li, M., Zhou, B., Zhou, A., Parsons, R. E., & Gu, W. J. (2013) · Cell Research · doi:10.1038/cr.2013.27 · Cited by 68
Jiang, L., Xiong, J., Zhan, J., Yuan, F., Tang, M., Zhang, C., Cao, Z., Chen, Y., Lu, X., Li, Y., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780130 · Cited by 71
PTEN Nuclear FunctionsPreprint
Ho, J., Cruise, E. S., Dowling, R. J. O., & Stambolic, V. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036079 · Cited by 68
Yang, W., Jin, G., Li, C., Jeong, Y. S., Moten, A., Xu, D., Feng, Z., Chen, W., Cai, Z., Darnay, B. G., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003197 · Cited by 67
Expression of USP7 and MARCH7 Is Correlated with Poor Prognosis in Epithelial Ovarian Cancer
Zhang, L., Wang, H., Tian, L., & Li, H. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.239.165 · Cited by 67
USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia
Shan, H., Li, X., Xiao, X., Dai, Y., Huang, J., Song, J., Liu, M., Yang, L., Lei, H., Tong, Y., et al. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0028-3 · Cited by 66
The role of UBL domains in ubiquitin-specific proteases
Faesen, A. C., Luna‐Vargas, M. P. A., & Sixma, T. K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120004 · Cited by 66
Role of retinoids in the prevention and treatment of colorectal cancer
Applegate, C. C., & Lane, M. A. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i10.184 · Cited by 65
Differential p53-Independent Outcomes of p19 Arf Loss in Oncogenesis
Chen, Z., Carracedo, A., Lin, H., Koutcher, J. A., Behrendt, N., Egia, A., Alimonti, A., Carver, B. S., Gerald, W. L., Teruya‐Feldstein, J., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000053 · Cited by 66
Self-citationMolusky, M. M., Li, S., Ma, D., Yu, L., & Lin, J. D. (2012) · Diabetes · doi:10.2337/db11-0970 · Cited by 65
Liu, H., Zhang, Q., Li, K., Gong, Z., Liu, Z., Xu, Y., Swaney, M. H., Xiao, K., & Chen, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.13219 · Cited by 63
Discovery of a Potent and Selective Degrader for USP7
Pei, Y., Fu, J., Shi, Y., Zhang, M., Luo, G., Luo, X., Song, N., Mi, T., Yang, Y., Li, J. X., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204395 · Cited by 68
Highlights in USP7 inhibitors for cancer treatment
Oliveira, R. I., Guedes, R. A., & Salvador, J. A. R. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1005727 · Cited by 64
Identification and Characterization of USP7 Targets in Cancer Cells
Georges, A. A., Marcon, E., Greenblatt, J. F., & Frappier, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-34197-x · Cited by 67
Hernández-Pérez, S., Cabrera, E., Salido, E., Lim, M., Reid, L., Lakhani, S. R., Khanna, K. K., Saunus, J. M., & Freire, R. (2017) · Oncogene · doi:10.1038/onc.2017.21 · Cited by 61
Expression of HAUSP in gliomas correlates with disease progression and survival of patients
Cheng, C., Niu, C., Yang, Y., Wang, Y., & Lu, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2342 · Cited by 63
Gao, R., Buechel, D., Kalathur, R. K. R., Morini, M. F., Coto‐Llerena, M., Ercan, C., Piscuoglio, S., Chen, Q., Blumer, T., Wang, X., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00338-7 · Cited by 62
Dual-utility NLS drives RNF169-dependent DNA damage responses
An, L., Jiang, Y., Ng, H. H. W., Man, E. P. S., Chen, J., Khoo, U., Gong, Q., & Huen, M. S. Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616602114 · Cited by 61
Sarkari, F., Wang, X., Nguyen, T., & Frappier, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016598 · Cited by 59
Xu, W., Zhen, Y., Zhou, S., & Lü, N. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s71061 · Cited by 59
Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role
Shen, S.-M., Ji, Y., Zhang, C., Dong, S.-S., Yang, S., Xiong, Z., Ge, M.-K., Yu, Y., Li, X., Guo, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04760-1 · Cited by 59
A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer
Satija, Y. K., Bhardwaj, A., & Das, S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28129 · Cited by 58
Gene expression control by protein deubiquitinases
Frappier, L., & Verrijzer, C. P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.02.005 · Cited by 60
Maccario, H., Perera, N. M., Gray, A., Downes, C. P., & Leslie, N. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072280 · Cited by 58
The ubiquitin system: orchestrating cellular signals in non-small-cell lung cancer
Fan, Q., Wang, Q., Cai, R., Yuan, H., & Xu, M. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0193-6 · Cited by 58
HAUSP , a novel deubiquitinase for Rb – MDM 2 the critical regulator
Bhattacharya, S., & Ghosh, M. K. (2014) · FEBS Journal · doi:10.1111/febs.12843 · Cited by 58
Kim, R. Q., van Dijk, W. J., & Sixma, T. K. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.05.005 · Cited by 61
The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival
He, Y., Wang, S., Tong, J., Jiang, S., Yang, Y., Zhang, Z., Xu, Y., Zeng, Y., Cao, B., Moran, M. F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010724 · Cited by 55
USP7‐TRIM27 axis negatively modulates antiviral type I IFN signaling
Cai, J., Chen, H., Peng, S., Meng, J., Wang, Y., Zhou, Y. J., Qian, X., Sun, X., Pang, X., Zhang, Y., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700473rr · Cited by 55
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications
Fulda, S., Rajalingam, K., & Đikić, I. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100707 · Cited by 57
Forand, A., Koumakis, E., Rousseau, A., Sassier, Y., Journé, C., Merlin, J.-F., Leroy, C., Boitez, V., Codogno, P., Friedlander, G., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.012 · Cited by 57
The ISG15-specific protease USP18 regulates stability of PTEN
Mustachio, L. M., Kawakami, M., Lu, Y., Rodriguez‐Canales, J., Mino, B., Behrens, C., Wistuba, I. I., Bota‐Rabassedas, N., Yu, J. Q., Lee, J. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13914 · Cited by 54
Tang, Y., Lv, L., Li, W., Zhang, X., Jiang, Y., Ge, W., & Zhou, Y. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0637-8 · Cited by 56
E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability
Xu, H., Ju, L., Xiong, Y., Yu, M., Zhou, F., Qian, K., Wang, G., Xiao, Y., & Wang, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03521-1 · Cited by 54
Targeting ubiquitination in disease and therapy
Yang, X., Lan, T., Zhang, B., Tao, X., Qi, W., Xie, K., Cai, Y., Liu, C., Han, J., & Wu, H. M. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02392-8 · Cited by 55
Ubiquitin-Specific Proteases as Cancer Drug Targets
Sippl, W., Collura, V., & Colland, F. (2011) · Future Oncology · doi:10.2217/fon.11.39 · Cited by 53
Yu, N., & Ma, M. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s100050 · Cited by 53
Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease
Rawat, R., Starczynowski, D. T., & Ntziachristos, P. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.02.008 · Cited by 54
Wang, F., Wang, L., Wu, J., Sokirniy, I., Nguyen, P., Bregnard, T. A., Weinstock, J., Mattern, M. R., Bezsonova, I., Hancock, W. W., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189744 · Cited by 52
Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy
Harakandi, C., Nininahazwe, L., Xu, H., Liu, B., He, C., Zheng, Y., & Zhang, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105273 · Cited by 53
PNUTS Functions as a Proto-Oncogene by Sequestering PTEN
Kavela, S., Shinde, S. R., Ratheesh, R., Kotapalli, V., Bashyam, M. D., Gowrishankar, S., Vamsy, M., Pattnaik, S., Rao, S., Sastry, R. A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1394 · Cited by 52
Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy
Allende-Vega, N., & Saville, M. K. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.004 · Cited by 51
Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia
Luesink, M., & Jansen, J. H. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08325.x · Cited by 51
Metadata
- Authors
- Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Pandolfi, Pier Paolo
- Venue
- Nature
- Published
- 2008-08-20
- Volume
- 455
- Issue
- 7214
- Pages
- 813-817
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3398484
- OpenAlex
- W2162648910
- Cited by
- 548
- References
- 34
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 22 · 2023: 35 · 2022: 25 · 2021: 37 · 2020: 43 · 2019: 40 · 2018: 33 · 2017: 39 · 2016: 34 · 2015: 36 · 2014: 32 · 2013: 27 · 2012: 31
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- European Molecular Biology Organization
- National Institutes of Health
- National Cancer Institute (R01CA082328, P50CA092629)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PTEN, USP7, PML, nuclear localization, PML nuclear bodies, DAXX, PML-RARA fusion, acute promyelocytic leukemia, all-trans retinoic acid, arsenic trioxide, prostate cancer, tumor suppressor regulation, ubiquitination, nuclear-cytoplasmic trafficking
- MeSH terms
- Promyelocytic Leukemia Protein, Ubiquitin-Specific Peptidase 7, Animals, Cell Nucleus, Fibroblasts, Humans, Male, Nuclear Proteins, Prostatic Neoplasms, Transcription Factors, Tretinoin, Ubiquitins, Leukemia, Promyelocytic, Acute, Apoptosis, Molecular Chaperones, Active Transport, Cell Nucleus, Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Cell Line, Tumor, Adaptor Proteins, Signal Transducing, PTEN Phosphohydrolase, Mice, Ubiquitination, Co-Repressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review